These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23086545)

  • 1. Iodine-123 metaiodobenzylguanidine imaging can predict future cardiac events in Japanese patients with Parkinson's disease.
    Kinbara T; Hayano T; Otani N; Furutani Y; Tanaka S
    Ann Nucl Med; 2013 Feb; 27(2):123-31. PubMed ID: 23086545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
    Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N
    J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Takahashi N; Okada N; Shinohara T; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Circ J; 2012; 76(2):399-404. PubMed ID: 22130318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of 5 Minutes
    Frantellizzi V; Ricci M; Farcomeni A; Pontico M; Pani A; Vincentis G
    Curr Radiopharm; 2020; 13(2):120-129. PubMed ID: 31985388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
    Imamura Y; Fukuyama T
    Ann Nucl Med; 2002 Sep; 16(6):387-93. PubMed ID: 12416577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.
    Momose M; Okayama D; Nagamatsu H; Kondo C; Hagiwara N; Sakai S
    Ann Nucl Med; 2011 Jul; 25(6):419-24. PubMed ID: 21461599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
    Nagamatsu H; Momose M; Kobayashi H; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Nov; 21(9):513-20. PubMed ID: 18030583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease.
    Shindo K; Kaneko E; Watanabe H; Sugimoto T; Ohta E; Ohashi K; Nagasaka T; Shiozawa Z
    Mov Disord; 2005 Nov; 20(11):1419-24. PubMed ID: 16007621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.
    Kioka H; Yamada T; Mine T; Morita T; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Hori M; Fukunami M
    Heart; 2007 Oct; 93(10):1213-8. PubMed ID: 17344327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
    Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
    Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.
    Kasama S; Toyama T; Kaneko Y; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1056-64. PubMed ID: 22415599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
    Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
    J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Heart; 2011 Jan; 97(1):20-6. PubMed ID: 21062772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early effects of transcatheter aortic valve replacement on cardiac sympathetic nervous function assessed by
    Kadoya Y; Zen K; Tamaki N; Ito N; Kuwabara K; Yamano M; Yamano T; Nakamura T; Matsushima S; Oka K; Numata S; Yaku H; Matoba S
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(7):1657-1667. PubMed ID: 31502014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.
    Mizutani Y; Ito S; Murate K; Hirota S; Fukui T; Hikichi C; Ishikawa T; Shima S; Ueda A; Kizawa M; Asakura K; Mutoh T
    J Neurol Sci; 2015 Dec; 359(1-2):236-40. PubMed ID: 26671120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.